Proton-pump inhibitors, prokinetics, antacid systems, enzyme preparations and hepatoprotectives.
The gastrointestinal range is built around the proton-pump inhibitor class and its established combinations with domperidone, levosulpiride and itopride, extended by the potassium-competitive acid blocker vonoprazan. Alongside these sit antacid and alginate suspensions, digestive enzyme preparations, antiemetics and silymarin-based hepatoprotectives. Oral solids and liquid dosage forms are produced on separate dedicated lines, which allows a single molecule to be offered as tablet, capsule, syrup and oral drops without shared-equipment cross-contamination risk.
Our DSIR-approved R&D center continuously executes complex technology transfers and formulation development. If your required therapeutic is not listed in our active commercial matrix, contact our technical team to initiate a custom Contract Manufacturing (CDMO) project.
Submit CDMO / Tech-Transfer Inquiry
